New York, NY-- November 9, 2018 -- InvestorsHub NewsWire -- Generex Biotechnology Corp (OTCQB: GNBT) has recent analyst coverage with a published $40 PPS target.  The company has recently realized a high of $25 per share.  Last week the company announced finalizing the acquisition of an operating company, but the pro-forma financials have not yet been released.  GNBT has great pharmaceutical IP, but little recent historical revenue.  When the pro-forma financials on the recent acquisition are published per regulatory requirements, GNBT is likely to realize substantial market attention.  With a $30 million purchase price, the acquired asset is likely to come with even more annual revenue than the purchase price as purchase prices for service operations are usually a multiple of margin, not revenue.  When GNBT posts the pro-forma financials or discloses the acquired revenue in a subsequent events narrative in its pending quarterly report, the GNBT PPS could top its recent $25 PPS or even push higher toward the analyst $40 PPS target.  The $16 PPS close yesterday looks like a great entry point today.

Learn more about Generex at http://www.generex.com/

Other PPS movers worth watching include Puration, Inc. (USOTC: PURA) reaching a recent $0.25 PPS all time high and pulling back to $0.10 with what looks like good news on the horizon.  Another potential mover to keep an eye on is Optec International, Inc. (USOTC: OPTI) at a $5.00 PPS and having just entered the white hot urban electric scooter market with Uber, Lyft and now Ford Motor Company.  The final recommendation to watch for today is Potnetworks (USOTC: POTN) having just announced extending their substantial online sales into physical retail.

DISCLAIMER: NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Source: www.nextbigticker.com


 

Potnetwork (CE) (USOTC:POTN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Potnetwork (CE) Charts.
Potnetwork (CE) (USOTC:POTN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Potnetwork (CE) Charts.